284 related articles for article (PubMed ID: 17549405)
1. Molecular characterization of the desmoplastic tumor stroma in medullary thyroid carcinoma.
Koperek O; Scheuba C; Puri C; Birner P; Haslinger C; Rettig W; Niederle B; Kaserer K; Garin Chesa P
Int J Oncol; 2007 Jul; 31(1):59-67. PubMed ID: 17549405
[TBL] [Abstract][Full Text] [Related]
2. Expression of stromal cell markers in distinct compartments of human skin cancers.
Huber MA; Kraut N; Schweifer N; Dolznig H; Peter RU; Schubert RD; Scharffetter-Kochanek K; Pehamberger H; Garin-Chesa P
J Cutan Pathol; 2006 Feb; 33(2):145-55. PubMed ID: 16420310
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD34, alpha-smooth muscle actin, and transforming growth factor beta1 in squamous intraepithelial lesions and squamous cell carcinoma of the larynx and hypopharynx.
Kojc N; Zidar N; Vodopivec B; Gale N
Hum Pathol; 2005 Jan; 36(1):16-21. PubMed ID: 15712177
[TBL] [Abstract][Full Text] [Related]
4. Tenascin-C protein expression and mRNA splice variants in thyroid carcinoma.
Tseleni-Balafouta S; Gakiopoulou H; Fanourakis G; Voutsinas G; Balafoutas D; Patsouris E
Exp Mol Pathol; 2006 Apr; 80(2):177-82. PubMed ID: 16259977
[TBL] [Abstract][Full Text] [Related]
5. Expression of hypoxia-associated proteins in sporadic medullary thyroid cancer is associated with desmoplastic stroma reaction and lymph node metastasis and may indicate somatic mutations in the VHL gene.
Koperek O; Bergner O; Pichlhöfer B; Oberndorfer F; Hainfellner JA; Kaserer K; Horvat R; Harris AL; Niederle B; Birner P
J Pathol; 2011 Sep; 225(1):63-72. PubMed ID: 21630273
[TBL] [Abstract][Full Text] [Related]
6. [Histologic and immunohistochemical characterization of medullary thyroid carcinoma].
Abrosimov Aiu
Arkh Patol; 1996; 58(4):43-8. PubMed ID: 8967865
[TBL] [Abstract][Full Text] [Related]
7. Stromal myofibroblasts predict disease recurrence for colorectal cancer.
Tsujino T; Seshimo I; Yamamoto H; Ngan CY; Ezumi K; Takemasa I; Ikeda M; Sekimoto M; Matsuura N; Monden M
Clin Cancer Res; 2007 Apr; 13(7):2082-90. PubMed ID: 17404090
[TBL] [Abstract][Full Text] [Related]
8. Desmoplasia in medullary thyroid carcinoma: a reliable indicator of metastatic potential.
Koperek O; Scheuba C; Cherenko M; Neuhold N; De Micco C; Schmid KW; Niederle B; Kaserer K
Histopathology; 2008 Apr; 52(5):623-30. PubMed ID: 18370959
[TBL] [Abstract][Full Text] [Related]
9. Microvessel count: an indicator of poor outcome in medullary thyroid carcinoma but not in other types of thyroid carcinoma.
Fontanini G; Vignati S; Pacini F; Pollina L; Basolo F
Mod Pathol; 1996 Jun; 9(6):636-41. PubMed ID: 8782200
[TBL] [Abstract][Full Text] [Related]
10. Myofibroblastic stromal reaction and expression of tenascin-C and laminin in prostate adenocarcinoma.
Tomas D; Ulamec M; Hudolin T; Bulimbasić S; Belicza M; Kruslin B
Prostate Cancer Prostatic Dis; 2006; 9(4):414-9. PubMed ID: 16652121
[TBL] [Abstract][Full Text] [Related]
11. Tenascin-C expression in Merkel cell carcinoma lymph node metastasis.
Koljonen V; Böhling T; Tukiainen E; Haglund C; Jahkola T
APMIS; 2006 Jan; 114(1):39-42. PubMed ID: 16499659
[TBL] [Abstract][Full Text] [Related]
12. HLA class II expression in well differentiated thyroid carcinoma: correlation with clinicopathological features.
Knoll MR; Schwab M; Oestreich K; Rumstadt B; Hagmüller E
J Exp Clin Cancer Res; 1997 Jun; 16(2):177-82. PubMed ID: 9261744
[TBL] [Abstract][Full Text] [Related]
13. Blood group antigens in differentiated thyroid neoplasms.
González-Cámpora R; García-Sanatana JA; Jordà i Heras MM; Salaverri CO; Vázquez-Ramírez FJ; Argueta-Manzano OE; Galera-Davidson H
Arch Pathol Lab Med; 1998 Nov; 122(11):957-65. PubMed ID: 9822123
[TBL] [Abstract][Full Text] [Related]
14. Concurrent papillary and medullary thyroid carcinomas with mixed metastases to lymph nodes.
Meshikhes AW; Tingura M; Al-Saeed JY
Saudi Med J; 2004 Mar; 25(3):373-5. PubMed ID: 15048181
[TBL] [Abstract][Full Text] [Related]
15. [Assay of thyrocalcitonin in cervical lymph node using fine-needle washings for the diagnosis of disseminated medullary thyroid carcinoma].
Isaev PA; Medvedev VS; Il'in AA; Rumiantsev PO; Chebotareva IV; Terent'ev PO; Abrosimov AIu; Vtiurin BM; Parshkov EM; Severskaia NV; Marchenko EV
Vopr Onkol; 2004; 50(1):46-9. PubMed ID: 15088520
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of fibroblast activation protein in patients with colon cancer.
Henry LR; Lee HO; Lee JS; Klein-Szanto A; Watts P; Ross EA; Chen WT; Cheng JD
Clin Cancer Res; 2007 Mar; 13(6):1736-41. PubMed ID: 17363526
[TBL] [Abstract][Full Text] [Related]
17. Characterization of cancer stroma markers: in silico analysis of an mRNA expression database for fibroblast activation protein and endosialin.
Dolznig H; Schweifer N; Puri C; Kraut N; Rettig WJ; Kerjaschki D; Garin-Chesa P
Cancer Immun; 2005 Aug; 5():10. PubMed ID: 16076089
[TBL] [Abstract][Full Text] [Related]
18. Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer.
Donnem T; Al-Saad S; Al-Shibli K; Delghandi MP; Persson M; Nilsen MN; Busund LT; Bremnes RM
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6649-57. PubMed ID: 18006765
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous occurrence of medullary and papillary carcinomas of the thyroid gland with metastases of papillary carcinoma to the cervical lymph nodes and the coinciding small B-cell lymphocytic lymphoma of the lymph nodes--a case report.
Bocian A; Kopczyński J; Rieske P; Piaskowski S; Słuszniak J; Kupnicka D; Góźdź S; Kowalska A; Sygut J
Pol J Pathol; 2004; 55(3):23-30. PubMed ID: 15619977
[TBL] [Abstract][Full Text] [Related]
20. The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastase.
Cappello F; David S; Rappa F; Bucchieri F; Marasà L; Bartolotta TE; Farina F; Zummo G
BMC Cancer; 2005 Oct; 5():139. PubMed ID: 16253146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
